Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Ingram

Showing results (441-450 of 507) with videos related to

Pageof 51
Sort By:
Molecular Cancer Therapeutics|April 1, 2024
Loss of the DNA Repair Gene RNase H2 Identifies a Unique Subset of DDR-Deficient LeiomyosarcomasMichael S Nakazawa, Ian M Silverman, Victoria Rimkunas, et al.
Archives of Dermatological Research|March 18, 2024
Methodological innovations and stakeholder involvement in core outcome sets for skin diseases: a survey of the C3 working groupsAreeba Ahmed, Eric Koza, Victoria Shi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 21, 2025
CA-125 as a Biomarker in Renal Medullary Carcinoma: Integrated Molecular Profiling, Functional Characterization, and Prospective Clinical ValidationSandra L Grimm, Menuka Karki, Kyle A Blum, et al.
Dermatology (Basel, Switzerland)|February 14, 2024
The Global Hidradenitis Suppurativa Atlas Methodology: Combining Global Proportions in a Pooled AnalysisDorra Bouazzi, Rune K Andersen, Gabrielle R Vinding, et al.
JAAD International|November 17, 2022
Comparison of real-world treatment outcomes of systemic immunomodulating therapy in atopic dermatitis patients with dark and light skin typesAngela L Bosma, Wouter Ouwerkerk, Madeline J Heidema, et al.
The British Journal of Dermatology|January 29, 2025
The UK-Irish Atopic eczema Systemic TherApy Register (A-STAR): baseline characteristics of the cohortElizaveta Gribaleva, Kaitlyn Chan, Carlos Chivardi, et al.
The New England Journal of Medicine|March 17, 1983
Cerebral arterial spasm--a controlled trial of nimodipine in patients with subarachnoid hemorrhageG S Allen, H S Ahn, T J Preziosi, et al.
Dermatology and Therapy|May 23, 2026
Criteria for Hidradenitis Suppurativa Competence CentersAngelo V Marzano, Falk G Bechara, Vivian Y Shi, et al.
The British Journal of Dermatology|July 24, 2024
A prospective observational cohort study comparing the treatment effectiveness and safety of ciclosporin, dupilumab and methotrexate in adult and paediatric patients with atopic dermatitis: results from the UK-Irish A-STAR registerHelen Alexander, Rayka Malek, David Prieto-Merino, et al.
International Journal of Dermatology|May 18, 2026
Position Statement of the EADV Task Forces With External Experts on Quality of Life Measurement in Hidradenitis Suppurativa: An UpdatePavel V Chernyshov, Gregor Jemec, Andrew Finlay, et al.
Pageof 51

Showing results (441-450 of 507) with videos related to

Sort By:
Pageof 51
Molecular Cancer Therapeutics|April 1, 2024
Loss of the DNA Repair Gene RNase H2 Identifies a Unique Subset of DDR-Deficient LeiomyosarcomasMichael S Nakazawa, Ian M Silverman, Victoria Rimkunas, et al.
Archives of Dermatological Research|March 18, 2024
Methodological innovations and stakeholder involvement in core outcome sets for skin diseases: a survey of the C3 working groupsAreeba Ahmed, Eric Koza, Victoria Shi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 21, 2025
CA-125 as a Biomarker in Renal Medullary Carcinoma: Integrated Molecular Profiling, Functional Characterization, and Prospective Clinical ValidationSandra L Grimm, Menuka Karki, Kyle A Blum, et al.
Dermatology (Basel, Switzerland)|February 14, 2024
The Global Hidradenitis Suppurativa Atlas Methodology: Combining Global Proportions in a Pooled AnalysisDorra Bouazzi, Rune K Andersen, Gabrielle R Vinding, et al.
JAAD International|November 17, 2022
Comparison of real-world treatment outcomes of systemic immunomodulating therapy in atopic dermatitis patients with dark and light skin typesAngela L Bosma, Wouter Ouwerkerk, Madeline J Heidema, et al.
The British Journal of Dermatology|January 29, 2025
The UK-Irish Atopic eczema Systemic TherApy Register (A-STAR): baseline characteristics of the cohortElizaveta Gribaleva, Kaitlyn Chan, Carlos Chivardi, et al.
The New England Journal of Medicine|March 17, 1983
Cerebral arterial spasm--a controlled trial of nimodipine in patients with subarachnoid hemorrhageG S Allen, H S Ahn, T J Preziosi, et al.
Dermatology and Therapy|May 23, 2026
Criteria for Hidradenitis Suppurativa Competence CentersAngelo V Marzano, Falk G Bechara, Vivian Y Shi, et al.
The British Journal of Dermatology|July 24, 2024
A prospective observational cohort study comparing the treatment effectiveness and safety of ciclosporin, dupilumab and methotrexate in adult and paediatric patients with atopic dermatitis: results from the UK-Irish A-STAR registerHelen Alexander, Rayka Malek, David Prieto-Merino, et al.
International Journal of Dermatology|May 18, 2026
Position Statement of the EADV Task Forces With External Experts on Quality of Life Measurement in Hidradenitis Suppurativa: An UpdatePavel V Chernyshov, Gregor Jemec, Andrew Finlay, et al.
Pageof 51